Emily J. McGlame

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

AbbVie (United States)(Current)

AbbVie (Germany)

Emily J. McGlame is an author at AbbVie (United States) specializing in life sciences, neuropeptide receptor subtypes, and neurodegenerative diseases.

ORCID

Publications per year

2021–2024

Publications

Distinct neuropeptide-receptor modules regulate a sex-specific behavioral response to a pheromone

Douglas K. Reilly, Emily J. McGlame, Elke Vandewyer et al. · Communications Biology · 2021 · 20 citations · Full text

Life Sciences, Biology, Entomology +16

Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain

Martina P. Morawe, Fan Liao, Willi Amberg et al. · European Journal of Pharmacology · 2022 · 18 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer’s disease reveals distinct sequential responses to Aβ and tau

Astrid Wachter, Maya E. Woodbury, Sylvia Lombardo et al. · Acta Neuropathologica · 2024 · 16 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

1–3 of 3